|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's range||27.47 - 28.20|
|52-week range||27.47 - 28.20|
|Beta (5Y monthly)||1.31|
|PE ratio (TTM)||159.32|
|Earnings date||25 Feb 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Cara (CARA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Investors need to pay close attention to Cara Therapeutics (CARA) stock based on the movements in the options market lately.
What happened Shares of Cara Therapeutics (NASDAQ: CARA) were soaring 13.1% higher as of 10:45 a.m. EDT on Tuesday. The big gain came after S&P Global division S&P Dow Jones Indices announced that Cara will replace MTS Systems in the S&P SmallCap 600 index.